http://feedback.nih.gov Using mHealth for the Precision Medicine Cohort Posted on July 6, 2015 Large studies on health and disease typically collect health and lifestyle data on participant volunteers from medical records and extensive phone or paper surveys. The Precision Medicine Initiative is considering using smart phone and wireless technologies to collect some of this information. These devices could provide the ability to track health behaviors and environmental exposures much more frequently with minimal burden on participants. For example, participant volunteers could respond to a few questions multiple times per day via their smart phones about their health status, activities, emotional states, etc. Location information from their smart phone or wearable device could be used to assess daily activity and also detect exposure to air pollution, etc. Wearable devices can assess heart rate and other physiological states as well as physical activity levels. Smartphones also could keep participants connected to the study, providing feedback on the data they provide as well as the aggregate data and findings of the study. The use of these mobile and wireless devices generates a number of considerations: Willingness of participants to carry their smartphone and wear wireless sensor devices sufficiently throughout the day so researchers can assess their health and activities. Willingness of participants without smartphones to upgrade to a smartphone at no expense. How often people would be willing to let researchers collect data through devices without being an inconvenience. The kind of information participants might like to receive back from researchers, and how often. Other ways to conveniently collect information from participants apart from smart phones or wearable devices. We’d like your thoughts on using smart phone and wireless technologies to collect information. Please note this is not related to ME patient population and I believe their Precision Medicine Cohort will start with cancer patients. But it is a good idea for patients of all kinds to get involved, and perhaps an opportunity to ask NIH to not leave the most neglected patients and diseases behind.